Media

Diabetes: An Open Dialogue on Discovery & Progression

To kick-off National Diabetes Awareness month, we've turned over the floor to our panel to provide an open dialogue on their journey with Diabetes type 2, from discovery to treatment to top communication methods in receiving industry updates. Hear them speak directly to big pharma and insurance companies regarding issues within the system that directly impact their experiences living with Diabetes, and in which particular areas they would like to see advancements.

Read the Infographic
Quirks October 2018: Medical Market Research Provider Issue

SHC ranked Top 26 Medical Market Research Companies, as seen in October's issue of Quirks! Additionally, we've gone pink! Check out our ad on page 54 to find out how we are supporting women in the fight against Breast Cancer!

Read the issue here
Making Strides Against Breast Cancer

In honor of Breast Cancer awareness month, and with our Making Strides Against Breast Cancer Walk fast-approaching, SHC surveyed 340+ OBGYNs and PCPs on their insights and predictions on the future of mammography.

Read the Infographic
SHC Eye Care Expertise

Since 2017, SHC has completed 100+ projects surrounding eye care, delivering close to 8,000 completes for our clients. From these studies, pulled together the estimated incidence by specific disease that are highlighted below. By leveraging our proprietary technology, we have the knowledge and expertise to ensure perfect delivery for our clients.

Read the White Paper
SHC Endocrinology Expertise

Since 2017, SHC has completed close to 150 Endocrinology projects, delivering more than 12,000 completes for our clients. From these studies, pulled together the estimated incidence by specific disease that are highlighted below. By leveraging our proprietary technology, we have the knowledge and expertise to ensure perfect delivery for our clients.

Read the White Paper
SHC Oncology Expertise

Since 2017, SHC has completed 1,400+ Oncology projects, delivering more than 45,000 completes to for clients. From these studies, pulled together the estimated incidence by specific disease that are highlighted below. By leveraging our proprietary technology, we have the knowledge and expertise to ensure perfect delivery for our clients.

Read the White Paper
Travel Vaccinations: New Study Findings

As TSA officials anticipate over 20% higher volume of travelers this summer, we wanted to see where our fellow globe-trotters stack up against preventative measures for diseases abroad. We surveyed more than 130 physicians from our proprietary panel on their recent experiences with patients and travel vaccines. We found it particularly interesting that the number 1 illness that travelers return home with, only ranks 4th for the most administered vaccine.

Read the White Paper
Expert Qualitative Research Forum — Challenges & Misconceptions of Recruiting & Fielding

Two Qualitative experts, Caroline Volpe, President of Compass Market Research, and Patrice Barnes, Director, Qualitative Operations, Naxion, join forces with SHC for a Q&A on the challenges and misconceptions they've faced within their combined 50+ years of healthcare market research.

Read the White Paper
E.coli Coast to Coast

Consumers and businesses are still struggling with the impact of the recent nationwide outbreak of E.coli. In fact, on Friday, June 1, the CDC announced four additional deaths and 25 new cases, now spanning across 35 states, coast to coast. Although the FDA confirmed that the outbreak was linked specifically to romaine lettuce grown in the Yuma, AZ region, the majority of those infected were reported from the northeast region. Without being able to pinpoint a single grower, harvester, processor, from which caused the illness, this ultimately poses the question -- is anyone safe?

Read the White Paper
GDPR Compliance

MAY 15, 2018, LONDON, UK: With the 25 May General Data Protection Regulation (GDPR) deadline fast approaching, SHC has spent a significant amount of effort implementing processes and procedures to comply with the legal obligations of GDPR, while maintaining full transparency with our clients, employees, and other individuals regarding the usage of their data.

Read the White Paper